Connor, Clark & Lunn Investment Management Ltd. Iradimed Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Iradimed Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 13,385 shares of IRMD stock, worth $723,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,385
Previous 8,677
54.26%
Holding current value
$723,726
Previous $381,000
76.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IRMD
# of Institutions
140Shares Held
6.59MCall Options Held
0Put Options Held
0-
Nine Ten Capital Management LLC Evanston, IL906KShares$49 Million13.77% of portfolio
-
Black Rock Inc. New York, NY818KShares$44.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny539KShares$29.2 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA514KShares$27.8 Million0.0% of portfolio
-
Copeland Capital Management, LLC422KShares$22.8 Million0.38% of portfolio
About IRADIMED CORP
- Ticker IRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 12,565,100
- Market Cap $679M
- Description
- IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...